{
    "startDate": "2017-01-01",
    "endDate": "2017-09-30",
    "year": "2017",
    "quarter": "Q3",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 159184000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 851624000
            },
            {
                "label": "Contracts receivable",
                "concept": "ReceivablesLongTermContractsOrPrograms",
                "unit": "usd",
                "value": 42924000
            },
            {
                "label": "Inventories",
                "concept": "InventoryRawMaterialsNetOfReserves",
                "unit": "usd",
                "value": 8451000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 48930000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1111113000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 116624000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2916000
            },
            {
                "label": "Total",
                "concept": "Assets",
                "unit": "usd",
                "value": 1252561000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 23525000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 15186000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 33963000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 104913000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 177647000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 79656000
            },
            {
                "label": "1 percent convertible senior notes",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": 524744000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 59750000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 854893000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 124,619,363 and 120,351,480 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 1528186000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -30199000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1190144000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 307968000
            },
            {
                "label": "Noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 89700000
            },
            {
                "label": "Beginning balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 397668000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 1252561000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12636000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 6138000
            },
            {
                "label": "Amortization of premium on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -5227000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 1202000
            },
            {
                "label": "Amortization of convertible senior notes discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 22963000
            },
            {
                "label": "Amortization of long-term financing liability for leased facility",
                "concept": "AmortizationOfLeasedAsset",
                "unit": "usd",
                "value": 3659000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 63642000
            },
            {
                "label": "Loss on extinguishment of financing liability for leased facility",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -7689000
            },
            {
                "label": "Non-cash losses related to patents, licensing and property, plant and equipment",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": -403000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 962000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 34866000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1707000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -8999000
            },
            {
                "label": "Deferred contract revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 42091000
            },
            {
                "label": "Operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 153748000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 589655000
            },
            {
                "label": "Proceeds from the sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 313860000
            },
            {
                "label": "Research and Development Facility [Abstract]",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 26502000
            },
            {
                "label": "Proceeds from the sale of Regulus Therapeutics stock",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": 2507000
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -304079000
            },
            {
                "label": "Proceeds from equity awards",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 17672000
            },
            {
                "label": "Proceeds from the issuance of common stock in Akcea Therapeutics, Inc. from its initial public offering, net of underwriters' discount",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 110438000
            },
            {
                "label": "Proceeds from building mortgage debt, net of issuance costs",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 59750000
            },
            {
                "label": "Proceeds from the issuance of common stock to Novartis",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 71737000
            },
            {
                "label": "Proceeds from sale of Akcea Therapeutics, Inc. common stock to Novartis in a private placement",
                "concept": "ProceedsFromIssuanceOfPrivatePlacement",
                "unit": "usd",
                "value": 50000000
            },
            {
                "label": "Offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 1057000
            },
            {
                "label": "Proceeds from borrowing on line of credit facility",
                "concept": "ProceedsFromLinesOfCredit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Principal payments on debt and capital lease obligations",
                "concept": "RepaymentsOfLongTermDebtAndCapitalSecurities",
                "unit": "usd",
                "value": 3577000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 224830000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 74499000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 4020000
            }
        ],
        "ic": [
            {
                "label": "SPINRAZA royalties",
                "concept": "RoyaltyRevenue",
                "unit": "usd",
                "value": 60467000
            },
            {
                "label": "Total revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 335367000
            },
            {
                "label": "Selling, General and Administrative [Member]",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 62782000
            },
            {
                "label": "Expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 309140000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 26227000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 7504000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 33966000
            },
            {
                "label": "Loss on extinguishment of financing liability for leased facility",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -7689000
            },
            {
                "label": "Other expenses",
                "concept": "OtherNonoperatingExpense",
                "unit": "usd",
                "value": 3528000
            },
            {
                "label": "Income (loss) before income tax expense",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -11452000
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 1184000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12636000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -3920000
            },
            {
                "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8716000
            },
            {
                "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.02
            },
            {
                "label": "Shares used in computing basic net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 123746000
            },
            {
                "label": "Diluted net income per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.02
            },
            {
                "label": "Shares used in computing diluted net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 125858000
            },
            {
                "label": "Unrealized gains (losses) on securities, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 587000
            },
            {
                "label": "Reclassification adjustment for realized gains included in net income (loss)",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": 374000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -86000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -12509000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -3952000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -8557000
            }
        ]
    }
}